| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.21 |
2e-05 |
| mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-05 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
CP724714 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0008 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0009 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
0.001 |